-
November 07, 2012
Can Endo reestablish itself as a quality healthcare name?
-
November 07, 2012
Bayer announced November 2 that it's buying Schiff for $1.2 billion to bulk up its consumer business.
-
November 05, 2012
Isis Pharmaceuticals Inc. (ISIS) recently announced that Pfizer Inc. (PFE) will move EXC 001 (also known as as ...
-
November 05, 2012
Teva has restructuring and growth opportunities, but the risk is still elevated.
-
November 02, 2012
Benchmarks finished in the green on the first trading day of November banking on positive consumer confidence and ...
-
November 01, 2012
Pfizer Inc. (PFE) posted third quarter earnings of 53 cents per share, a penny above the Zacks Consensus Estimate ...
-
November 01, 2012
GlaxoSmithKline (GSK) reported third quarter 2012 earnings of 71 cents per American Depository Share (ADS), well ...
-
November 01, 2012
We have a flood of economic and earnings reports this morning, but the focus will be on the labor market today ahead ...
-
November 01, 2012
Thursday, November 1, 2012 We have a flood of economic and earnings reports this morning, but the focus will be ...
-
November 01, 2012
Pfizer (NYSE:PFE) announced its results for the most recent quarter on November 1, 2012. Pfizer is a global ...
-
October 31, 2012
Recently, the HealthCare unit of Bayer (BAYRY) announced that its oncology drug Stivarga (regorafenib) will be ...
-
October 31, 2012
Dr. Reddy's Laboratories (RDY) reported second quarter fiscal 2013 earnings per American Depositary Share (ADS) of ...
-
October 30, 2012
Markets remain closed for a second day on Tuesday due to Hurricane Sandy, with published accounts putting the ...
-
October 30, 2012
Tuesday, October 30, 2012 Markets remain closed for a second day on Tuesday due to Hurricane Sandy, with ...
-
October 25, 2012
Elan Corporation's (ELN) loss of 5 cents per share (excluding special items) for the second quarter of 2012 was ...
-
October 25, 2012
When Pfizer (NYSE:PFE) releases its third quarter earnings on Tuesday, October 30, 2012, analysts are expecting a ...
-
October 24, 2012
Bristol-Myers Squibb Company's (BMY) second quarter 2012 earnings (excluding special items) of 48 cents per share ...
-
October 24, 2012
Amgen (AMGN) continued its strong performance in 2012 with third quarter earnings coming in at $1.66 per share, 23 ...
-
October 19, 2012
New York, October 19th (TradersHuddle.com) - Shares of Pfizer, Inc. (NYSE:PFE) ended the trading
session higher ...
-
October 17, 2012
Denmark-based Novo Nordisk (NVO) is seeking regulatory approval for its hemophilia A candidate turoctocog alfa ...